Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

Serological assessment of the establishment of herd immunity against measles in a health district in Malaysia

Authors: Y. Hazlina, M. A. Marlindawati, K. Shamsuddin

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

Malaysia still faces challenges optimizing resources to effectively eliminate measles through high immunization and herd immunity, with sporadic outbreaks of measles as evidence. The objective of this study is to determine the age-specific positive measles antibodies seroprevalence used for assessing the establishment of herd immunity against measles in different age groups. This is useful for identifying vulnerable age groups requiring supplementary immunization.

Methods

A seroprevalence study was conducted among respondents aged 6–9 years, 15–24 years and 45–54 years attending government health clinics in Seremban between September 2014 and January 2015. A total of 1541 measles IgG antibody status were determined using ELISA technique (NovaTec Immundiagnostica GMBH) and assessment of establishment of herd immunity was based on indicators developed by Plans. Data on socio-demographic background as well as medical and medication history were also gathered.

Results

Seropositive rate for all respondents were 87% (95% CI 85–89), while the rest had either indeterminate [6% (95% CI 5–7)] or negative titre [7% (95% CI 6–8)]. None of the factors analyzed except for age were significant predictors of positive measles antibodies. Seropositive rate differed by age with the highest rate seen in adults (94%; CI 92–96), followed by children (90%; 95% CI 87–94) and adolescents, and young adults (74%; 95% CI 70–78). Based on Plans’ indicators, herd immunity was established in adults and children, but not in adolescents and young adults.

Conclusions

To tackle the most susceptible group in the present study, it is advisable to give booster vaccination to secondary school students and freshmen who enter colleges and universities in Malaysia.
Literature
1.
go back to reference Strebel PM, Cochi SL, Hoekstra E, Rota PA, Featherstone D, Bellini WJ, Katz SL. A world without measles. J Infect Dis. 2011;204 Suppl 1:S1–3.CrossRefPubMed Strebel PM, Cochi SL, Hoekstra E, Rota PA, Featherstone D, Bellini WJ, Katz SL. A world without measles. J Infect Dis. 2011;204 Suppl 1:S1–3.CrossRefPubMed
2.
go back to reference CDC. Progress in Global Measles Control and mortality reduction, 2000-2007. Morb Mortal Wkly Rep. 2008;57:1303–6. CDC. Progress in Global Measles Control and mortality reduction, 2000-2007. Morb Mortal Wkly Rep. 2008;57:1303–6.
3.
go back to reference CDC. Progress toward Measles Elimination-Western Pacific Region, 2009-2012. Morb Mortal Wkly Rep. 2013;62(22):443–7. CDC. Progress toward Measles Elimination-Western Pacific Region, 2009-2012. Morb Mortal Wkly Rep. 2013;62(22):443–7.
4.
go back to reference MOH. Measles Prevention and Control in Malaysia: Handbook for healthcare personnel. Kuala Lumpur: Ministry of Health, Malaysia; 2006. MOH. Measles Prevention and Control in Malaysia: Handbook for healthcare personnel. Kuala Lumpur: Ministry of Health, Malaysia; 2006.
5.
go back to reference Hollingsworth TD. Controlling infectious disease outbreaks: Lessons from mathematical modelling. J Public Health Policy. 2009;30(3):328–41.CrossRefPubMed Hollingsworth TD. Controlling infectious disease outbreaks: Lessons from mathematical modelling. J Public Health Policy. 2009;30(3):328–41.CrossRefPubMed
6.
go back to reference De Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol. 2000;151:1039–52.CrossRefPubMed De Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases after elimination. Am J Epidemiol. 2000;151:1039–52.CrossRefPubMed
7.
go back to reference Dominguez A, Plans P, Costa J, Torner N, Cardenosa N, Batalla J, et al. Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis. 2006;25:310–7.CrossRefPubMed Dominguez A, Plans P, Costa J, Torner N, Cardenosa N, Batalla J, et al. Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis. 2006;25:310–7.CrossRefPubMed
8.
go back to reference Plans P. Prevalence of antibodies associated with herd immunity: A new indicator to evaluate the establishment of herd immunity and to decide immunization strategies. Med Decis Mak. 2010;30:438–43.CrossRef Plans P. Prevalence of antibodies associated with herd immunity: A new indicator to evaluate the establishment of herd immunity and to decide immunization strategies. Med Decis Mak. 2010;30:438–43.CrossRef
9.
go back to reference Pocock SJ. Clinical Trials: A Practical Approach. Chichester: John Wiley and Sons; 1983. Pocock SJ. Clinical Trials: A Practical Approach. Chichester: John Wiley and Sons; 1983.
10.
go back to reference Saraswathy TS, Zahrin HN, Norshahmimi H, Az-Ulhusna A, Zainah S, Rohani J. Impact of measles elimination strategy on measles incidence in Malaysia. Southern Asian J Trop Med Public Health. 2009;40:742–7. Saraswathy TS, Zahrin HN, Norshahmimi H, Az-Ulhusna A, Zainah S, Rohani J. Impact of measles elimination strategy on measles incidence in Malaysia. Southern Asian J Trop Med Public Health. 2009;40:742–7.
12.
go back to reference Anderson RM. The concept of herd immunity and the design of community-based immunization programmes. Vaccine. 1992;10(13):928–35.CrossRefPubMed Anderson RM. The concept of herd immunity and the design of community-based immunization programmes. Vaccine. 1992;10(13):928–35.CrossRefPubMed
13.
go back to reference Georgette N. The quantification of the effects of changes in population parameters on the herd immunity threshold. Int J Epidemiol. 2007;5(1):5. Georgette N. The quantification of the effects of changes in population parameters on the herd immunity threshold. Int J Epidemiol. 2007;5(1):5.
14.
go back to reference Zhang X, Kou G, Du H, Ju Z, Zhong L, Cui X, et al. Measles epidemiology and survey of measles immunity level among healthy population in Baoji City, Shaanxi Province, China. Jpn J Infect Dis. 2013;66(5):1884–2836.CrossRef Zhang X, Kou G, Du H, Ju Z, Zhong L, Cui X, et al. Measles epidemiology and survey of measles immunity level among healthy population in Baoji City, Shaanxi Province, China. Jpn J Infect Dis. 2013;66(5):1884–2836.CrossRef
15.
go back to reference Levine H, Zarka S, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, et al. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal two-dose MMR vaccination in Israel. Human Vaccines Immunother. 2015;11(6):1400–5.CrossRef Levine H, Zarka S, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, et al. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal two-dose MMR vaccination in Israel. Human Vaccines Immunother. 2015;11(6):1400–5.CrossRef
16.
go back to reference Leuridan E, Sabbe M, Damme PPV. Measles outbreak in Europe: Susceptibility of infants too young to be immunized. Vaccine. 2012;30(41):5905–13.CrossRefPubMed Leuridan E, Sabbe M, Damme PPV. Measles outbreak in Europe: Susceptibility of infants too young to be immunized. Vaccine. 2012;30(41):5905–13.CrossRefPubMed
17.
go back to reference Markowitz LE, Preblud SR, Fine PE, Orenstein WA. Duration of live measles vaccines-induced immunity. Pediatr Infect Dis J. 1990;9:101–10.CrossRefPubMed Markowitz LE, Preblud SR, Fine PE, Orenstein WA. Duration of live measles vaccines-induced immunity. Pediatr Infect Dis J. 1990;9:101–10.CrossRefPubMed
18.
go back to reference LeBaron CW, Beeler J, Sullivan BJ, Forghani B, Bi D, Beck C, Audet S, Gargiullo P. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adolesc Med. 2007;161(3):294–301.CrossRefPubMed LeBaron CW, Beeler J, Sullivan BJ, Forghani B, Bi D, Beck C, Audet S, Gargiullo P. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adolesc Med. 2007;161(3):294–301.CrossRefPubMed
19.
go back to reference Sultana R, Rahman MM, Hassan Z, Hassan MS. Prevalence of IgG antibody against measles, mumps and rubella in Bangladeshi children: A pilot study to evaluate the need for integrated vaccination strategy. Scand J Immunol. 2006;64:684–9.CrossRefPubMed Sultana R, Rahman MM, Hassan Z, Hassan MS. Prevalence of IgG antibody against measles, mumps and rubella in Bangladeshi children: A pilot study to evaluate the need for integrated vaccination strategy. Scand J Immunol. 2006;64:684–9.CrossRefPubMed
20.
go back to reference Yekta Z, Porali R, Taravati MR, Salary S, Khalily F, Shahabi S. Measles IgG sero-prevalence and its attributable factors in 5-25-year-old cases prior mass vaccination campaign in Urmia, Northeastern Iran. Iranian Red Crescent Med J. 2007;9(1):28–35. Yekta Z, Porali R, Taravati MR, Salary S, Khalily F, Shahabi S. Measles IgG sero-prevalence and its attributable factors in 5-25-year-old cases prior mass vaccination campaign in Urmia, Northeastern Iran. Iranian Red Crescent Med J. 2007;9(1):28–35.
21.
go back to reference Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197:950–6.CrossRefPubMed Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197:950–6.CrossRefPubMed
22.
go back to reference Onoja AB, Adeniji AJ. Kinetics of measles antibody by hemagglutination inhibition assay in children in south-west and north-central Nigeria. Int J Infect Dis. 2013;17(7):e552–5.CrossRefPubMed Onoja AB, Adeniji AJ. Kinetics of measles antibody by hemagglutination inhibition assay in children in south-west and north-central Nigeria. Int J Infect Dis. 2013;17(7):e552–5.CrossRefPubMed
23.
go back to reference Poethko-Muller C, Mankertz A. Sero-epidemiology of measles specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross sectional study in children and adolescents (KiGGS). Vaccine. 2011;29(45):7949–59.CrossRefPubMed Poethko-Muller C, Mankertz A. Sero-epidemiology of measles specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross sectional study in children and adolescents (KiGGS). Vaccine. 2011;29(45):7949–59.CrossRefPubMed
24.
go back to reference Aaby P, Martins C, Bale C, Garly ML, Rodrigues A, Biai S, Lisse IM, Whittle H, Benn CS. Sex differences in the effect of vaccines on the risk of hospitalization due to measles in Guinea-Bissau. Paediatr Infect Dis J. 2010;29(4):324–8. Aaby P, Martins C, Bale C, Garly ML, Rodrigues A, Biai S, Lisse IM, Whittle H, Benn CS. Sex differences in the effect of vaccines on the risk of hospitalization due to measles in Guinea-Bissau. Paediatr Infect Dis J. 2010;29(4):324–8.
25.
go back to reference Stein-Zamir C, Abramson N, Shoob H, Zentner G. An outbreak of measles in an ultra-orthodox Jewish community in Jerusalem, Israel, 2007- an in-depth report. Eurosurveillance. 2008;13:8045.PubMed Stein-Zamir C, Abramson N, Shoob H, Zentner G. An outbreak of measles in an ultra-orthodox Jewish community in Jerusalem, Israel, 2007- an in-depth report. Eurosurveillance. 2008;13:8045.PubMed
26.
go back to reference Lernout T, Kissling E, Hutse V, De Schrijver K, Top G. An outbreak of measles in orthodox Jewish communities in Antwerp, Belgium, 2007–2008: different reasons for accumulation of susceptibles. Eurosurveillance. 2009;14:19087.PubMed Lernout T, Kissling E, Hutse V, De Schrijver K, Top G. An outbreak of measles in orthodox Jewish communities in Antwerp, Belgium, 2007–2008: different reasons for accumulation of susceptibles. Eurosurveillance. 2009;14:19087.PubMed
27.
go back to reference Anis E, Grotto I, Moerman L. Measles in a highly vaccinated society: the 2007–08 outbreaks in Israel. J Infect. 2009;59:252–8.CrossRefPubMed Anis E, Grotto I, Moerman L. Measles in a highly vaccinated society: the 2007–08 outbreaks in Israel. J Infect. 2009;59:252–8.CrossRefPubMed
28.
go back to reference Mixer RE, Jamrozik K, Newsom D. Ethnicity as a correlate of the uptake of the first dose of mumps, measles and rubella vaccine. J Epidemiol Community Health. 2007;61:797–801.CrossRefPubMedPubMedCentral Mixer RE, Jamrozik K, Newsom D. Ethnicity as a correlate of the uptake of the first dose of mumps, measles and rubella vaccine. J Epidemiol Community Health. 2007;61:797–801.CrossRefPubMedPubMedCentral
29.
go back to reference Baker D, Garrow A, Shiels C. Inequalities in immunisation and breast feeding in an ethnically diverse urban area: cross-sectional study in Manchester, UK. J Epidemiol Community Health. 2011;65:346–52.CrossRefPubMed Baker D, Garrow A, Shiels C. Inequalities in immunisation and breast feeding in an ethnically diverse urban area: cross-sectional study in Manchester, UK. J Epidemiol Community Health. 2011;65:346–52.CrossRefPubMed
30.
go back to reference McQuillan GM, Kruszon-Moran D, Hyde TB, Forghani B, Bellini W, Dayan GH. Seroprevalence of measles antibody in the US population, 1999–2004. J Infect Dis. 2007;196:1459–64.CrossRefPubMed McQuillan GM, Kruszon-Moran D, Hyde TB, Forghani B, Bellini W, Dayan GH. Seroprevalence of measles antibody in the US population, 1999–2004. J Infect Dis. 2007;196:1459–64.CrossRefPubMed
31.
go back to reference Senn N, Riddell M, Omena M, Siba P, Reeder JC, Clements CJ, Morgan C. Measles in Papua New Guinea: an age-specific serological survey. Vaccine. 2009;28(7):1819–23.CrossRefPubMed Senn N, Riddell M, Omena M, Siba P, Reeder JC, Clements CJ, Morgan C. Measles in Papua New Guinea: an age-specific serological survey. Vaccine. 2009;28(7):1819–23.CrossRefPubMed
32.
go back to reference Poethko-Muller C, Mankertz A. Seroprevalence of measles-, mumps- and rubella-specific igg antibodies in German children and adolescents and predictors for seronegativity. PLoS ONE. 2012;7(8):e42867.CrossRefPubMedPubMedCentral Poethko-Muller C, Mankertz A. Seroprevalence of measles-, mumps- and rubella-specific igg antibodies in German children and adolescents and predictors for seronegativity. PLoS ONE. 2012;7(8):e42867.CrossRefPubMedPubMedCentral
33.
go back to reference Heijstek MW, Gageldonk PGM, Berbers GAM, Wulffraat NM. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study. Ann Rheum Dis. 2012;71:948–54.CrossRefPubMed Heijstek MW, Gageldonk PGM, Berbers GAM, Wulffraat NM. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study. Ann Rheum Dis. 2012;71:948–54.CrossRefPubMed
34.
go back to reference Gluck T, Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis. 2008;46:1459–65.CrossRefPubMed Gluck T, Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis. 2008;46:1459–65.CrossRefPubMed
35.
go back to reference Dickerson F, Stallings C, Origoni A, Copp C, Khushalani S, Yolken R. Antibodies to measles in individuals with recent onset psychosis. Schizophr Res. 2010;119(1-3):89–94.CrossRefPubMed Dickerson F, Stallings C, Origoni A, Copp C, Khushalani S, Yolken R. Antibodies to measles in individuals with recent onset psychosis. Schizophr Res. 2010;119(1-3):89–94.CrossRefPubMed
36.
go back to reference Rosemawati A. Towards measles elimination – measles situation in Malaysia before. Infect Dis Bull. 2003;2005:8–9. Rosemawati A. Towards measles elimination – measles situation in Malaysia before. Infect Dis Bull. 2003;2005:8–9.
Metadata
Title
Serological assessment of the establishment of herd immunity against measles in a health district in Malaysia
Authors
Y. Hazlina
M. A. Marlindawati
K. Shamsuddin
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-2069-y

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.